Lucid Diagnostics (LUCD) Equity Ratio (2020 - 2026)

Lucid Diagnostics (LUCD) has 7 years of Equity Ratio data on file, last reported at 0.12 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio rose 171.59% year-over-year to 0.12; the trailing twelve-month figure through Mar 2026 stood at 0.12 (up 171.59% YoY), and the FY2025 full-year result was 0.27, up 54.05% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.12, down from 0.27 in the prior quarter.
• Across five years, Equity Ratio topped out at 0.8 in Q2 2022 and bottomed at 0.16 in Q1 2025.
• The 5-year median for Equity Ratio is 0.35 (2023), against an average of 0.36.
• The widest annual swing landed in 2024, when Equity Ratio jumped 307.11%; it then slumped 144.18% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.71 in 2022, then slumped by 111.95% to 0.08 in 2023, then jumped by 307.11% to 0.18 in 2024, then jumped by 54.05% to 0.27 in 2025, then sank by 56.59% to 0.12 in 2026.
• The last three Equity Ratio figures came in at 0.12 (Q1 2026), 0.27 (Q4 2025), and 0.49 (Q3 2025), per Business Quant data.

Peer Comparison